Ohio State Receives $12 Million to Study Effectiveness of Therapies for Gestational Diabetes
Ohio State University Wexner Medical CenterGestational diabetes is on the rise among pregnant people, and now Ohio State University Wexner Medical Center has received a $12 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to define the best treatment. The study will compare oral metformin versus injectable insulin.